Ovidrel, Ovitrelle(choriogonadotropin alfa)
Ovidrel, Ovitrelle (choriogonadotropin alfa) is a protein pharmaceutical. Choriogonadotropin alfa was first approved as Ovidrel on 2000-09-20. It is used to treat cryptorchidism, female infertility, and hypogonadism in the USA. It has been approved in Europe to treat anovulation, assisted reproductive techniques, and female infertility.
Download report
Favorite
Commercial
Trade Name
FDA
EMA
Ovidrel
Drug Products
FDA
EMA
Reference product - 351(a)
Reference product - 351(a)
Interchangeable product - 351(k)
Interchangeable product - 351(k)
Biosimilar product - 351(k)
Biosimilar product - 351(k)
Choriogonadotropin alfa
Tradename | Proper name | Company | Number | Date | Products |
|---|---|---|---|---|---|
| Ovidrel | choriogonadotropin alfa | EMD Serono | N-21149 RX | 2003-07-14 | 1 products |
Show 1 discontinued
Indications
FDA
EMA
Indication | Ontology | MeSH | ICD-10 |
|---|---|---|---|
| cryptorchidism | EFO_0004562 | D003456 | Q53.1 |
| female infertility | EFO_0008560 | D007247 | N97 |
| hypogonadism | HP_0000815 | D007006 | E23.0 |
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
HCPCS
No data
Clinical
Clinical Trials
123 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Infertility | D007246 | EFO_0000545 | 2 | 5 | 7 | 21 | 14 | 48 | |
| Fertilization in vitro | D005307 | 1 | 2 | 1 | 7 | 5 | 15 | ||
| Polycystic ovary syndrome | D011085 | EFO_0000660 | E28.2 | 1 | 2 | 4 | 3 | 2 | 10 |
| Female infertility | D007247 | EFO_0008560 | N97 | 1 | 1 | 1 | 3 | 4 | 9 |
| Hypogonadism | D007006 | E23.0 | 1 | 1 | 1 | 3 | 1 | 7 | |
| Kallmann syndrome | D017436 | Orphanet_478 | E23.0 | — | — | — | 4 | 2 | 6 |
| Intracytoplasmic sperm injections | D020554 | — | — | — | 4 | — | 4 | ||
| Ovarian hyperstimulation syndrome | D016471 | — | — | 1 | 2 | — | 3 | ||
| Fertility | D005298 | — | — | 1 | 1 | — | 2 | ||
| Embryo transfer | D004624 | — | — | 1 | 1 | — | 2 |
Show 2 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Klinefelter syndrome | D007713 | EFO_1001006 | Q98.0 | — | — | 1 | — | 1 | 2 |
| Anovulation | D000858 | — | — | 1 | — | — | 1 | ||
| Assisted reproductive techniques | D027724 | — | — | 1 | — | — | 1 |
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Ovulation induction | D010062 | — | 3 | — | — | 3 | 6 | ||
| Leiomyoma | D007889 | HP_0000131 | D25 | 1 | 1 | — | — | 1 | 2 |
| Primary ovarian insufficiency | D016649 | EFO_0004266 | E28.3 | 1 | 1 | — | — | 1 | 2 |
| Infections | D007239 | EFO_0000544 | 1 | 1 | — | — | — | 1 | |
| Endometriosis | D004715 | EFO_0001065 | N80 | 1 | 1 | — | — | — | 1 |
| Ectopic pregnancy | D011271 | O00 | 1 | 1 | — | — | — | 1 | |
| Salpingitis | D012488 | N70.91 | 1 | 1 | — | — | — | 1 | |
| Graft vs host disease | D006086 | D89.81 | 1 | 1 | — | — | — | 1 | |
| Endocrine system diseases | D004700 | EFO_0001379 | E34.9 | 1 | 1 | — | — | — | 1 |
| Gonadal disorders | D006058 | 1 | 1 | — | — | — | 1 |
Show 1 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Retinal diseases | D012164 | HP_0000479 | H35.9 | 1 | — | — | — | — | 1 |
| Healthy volunteers/patients | — | 1 | — | — | — | — | 1 |
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Pregnancy | D011247 | EFO_0002950 | Z33.1 | — | — | — | — | 2 | 2 |
| Reproductive behavior | D043762 | — | — | — | — | 1 | 1 | ||
| Premature obstetric labor | D007752 | O60 | — | — | — | — | 1 | 1 | |
| Eunuchism | D005058 | EFO_0007266 | E29.1 | — | — | — | — | 1 | 1 |
| Breast neoplasms | D001943 | EFO_0003869 | C50 | — | — | — | — | 1 | 1 |
| Spinal cord injuries | D013119 | EFO_1001919 | — | — | — | — | 1 | 1 | |
| Embryo implantation | D010064 | — | — | — | — | 1 | 1 | ||
| In vitro oocyte maturation techniques | D059471 | — | — | — | — | 1 | 1 |
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | CHORIOGONADOTROPIN ALFA |
| INN | choriogonadotropin alfa |
| Description | Choriogonadotropin beta chain [Precursor]; Glycoprotein hormones alpha chain [Precursor]; |
| Classification | Protein |
| Drug class | tricyclic compounds; atropine derivatives |
| Image (chem structure or protein) | |
| Structure (InChI/SMILES or Protein Sequence) | — |
Identifiers
| PDB | — |
| CAS-ID | 9002-61-3 |
| RxCUI | 4986 |
| ChEMBL ID | CHEMBL1201464 |
| ChEBI ID | — |
| PubChem CID | — |
| DrugBank | DB09126 |
| UNII ID | 6413W06WR3 (ChemIDplus, GSRS) |
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 1,453 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
50,140 adverse events reported
View more details
Premium feature
Learn more about premium features at pharmakb.com
Learn more